Supplemental Information Supplemental figure...

11
1 Supplemental Information Supplemental figure legends Figure S1. Supplemental figure for Fig. 1. A. Different methods of cell detachment similarly induce YAP phosphorylation. MCF10A cells were trypsinized and attached onto fibronectin-coated petri dishes for 2 hours. Cells were either directly lysed (Attach) or detached with Trypsin- EDTA, Trypsin alone, or EDTA alone. Samples were analyzed by western blots with anti-YAP antibody. Figure S2. Supplemental figure for Fig. 2. A. Cytochalasin D blocks cell attachment-induced YAP dephosphorylation. MCF10A cells were trypsinized (T) and attached onto fibronectin-coated petri dishes for 1.5 hours (A). Inhibitors were added at the time of plating as indicated. Cell lysates were resolved on Phos-tag-containing SDS-PAGE gels and western blot was done as indicated. B. Scr, FAK, ROCK, and microtubule inhibitors do not have significant effect on attachment-induced YAP dephosphorylation. Experiments were similar to that in A except different inhibitors were used. C. Scr, FAK, and actomyosin inhibitors do not block cell detachment-induced YAP phosphorylation. MCF10A cells were replated onto fibronectin-coated petri dishes for 1.5 hours. During the last half an hour, indicated inhibitors were added

Transcript of Supplemental Information Supplemental figure...

  •   1  

    Supplemental Information

    Supplemental figure legends

    Figure S1. Supplemental figure for Fig. 1.

    A. Different methods of cell detachment similarly induce YAP phosphorylation.

    MCF10A cells were trypsinized and attached onto fibronectin-coated petri dishes

    for 2 hours. Cells were either directly lysed (Attach) or detached with Trypsin-

    EDTA, Trypsin alone, or EDTA alone. Samples were analyzed by western blots

    with anti-YAP antibody.

    Figure S2. Supplemental figure for Fig. 2.

    A. Cytochalasin D blocks cell attachment-induced YAP dephosphorylation.

    MCF10A cells were trypsinized (T) and attached onto fibronectin-coated petri

    dishes for 1.5 hours (A). Inhibitors were added at the time of plating as indicated.

    Cell lysates were resolved on Phos-tag-containing SDS-PAGE gels and western

    blot was done as indicated.

    B. Scr, FAK, ROCK, and microtubule inhibitors do not have significant effect on

    attachment-induced YAP dephosphorylation. Experiments were similar to that in

    A except different inhibitors were used.

    C. Scr, FAK, and actomyosin inhibitors do not block cell detachment-induced YAP

    phosphorylation. MCF10A cells were replated onto fibronectin-coated petri

    dishes for 1.5 hours. During the last half an hour, indicated inhibitors were added

  •   2  

    to the culture medium. Cells were then trypsinized and lysed. Same

    concentrations of inhibitors were also included in trypsin.

    D. Actomyosin and ROCK inhibitors do not induce YAP dephosphorylation in cells

    cultured at high density. MCF10A cells cultured at high cell density were treated

    with indicated inhibitors for one hour. Cells were then lysed and cell lysates were

    resolved on Phos-tag-containing SDS-PAGE gels for western blot as indicated.

    E. Nocodazole disrupts microtubule and induces actin stress fibers. Cells were the

    same as these in Fig. 2F. Briefly, MCF10A cells were cultured onto fibronectin-

    coated cover glasses at high cell density. Cells were treated with nocodazole

    before fixation. Samples were then stained with anti-alpha-tubulin antibody for

    microtubule and Alexa Fluor 488-Phalloidin for F-actin.

    Figure S3. Supplemental figure for Fig. 4.

    A. RNAi efficiency for Fig. 4A. Cell lysates were analyzed by western blots for the

    expression of Lats1, Lats2, Mst1, and Mst2.

    B. RNAi efficiency for Fig. 4B,C. Cell lysates were analyzed by western blots for

    the expression of Lats1, Lats2, Mst1, and Mst2.

    C. Specificity of phospho-Lats1/2 antibodies. HEK293 cells were transfected with

    indicated plasmids. Lats2 was immunoprecipitated with anti-HA antibody and

    then treated with lambda protein phosphatase as indicated. Immunoprecipitates

    were analyzed by western blotting.

     Figure S4. Mst1/2 activity is not regulated by cell attachment.

  •   3  

    A. Cell attachment status does not regulate the activity of ectopically expressed

    Mst2. Plasmids encoding Flag-Mst2 was transfected into HeLa cells. Cells were

    freshly attached to fibronectin-coated petri dishes for 2 hours (A) or further

    trypsinized (T). Mst2 was then immunoprecipitated by anti-Flag antibody and was

    subjected to in vitro kinase assays using GST-Mob purified from E.coli as a

    substrate in the presence of 32P-ATP. The products were analyzed by

    autoradiograph.

    B. Cell attachment status does not regulate the activity of endogenous Mst1.

    Experiments were similar to that in A except that endogenous Mst1 was

    immunoprecipitated from HeLa cells.

    C. Mst2 phosphorylation is not regulated by cell attachment. Mst2 transfected HeLa

    cells were subjected to attachment for 2 hours (A) or further trypsinization (T).

    Mst2 phosphorylation was detected by a phosphoMst2 (T183)-specific antibody

    in western blotting.

    D. Mob phosphorylation is not regulated by cell attachment. MCF10A cells were

    subjected to trypsinization (T), followed by attachment for 2 hours (A), and then

    re-trypsinization (reT). Cell lysates were analyzed by western blotting for Mob

    phosphorylation on T35, a known Mst1/2 target phosphorylation site. Cells

    treated with hydrogen peroxide in a separate experiment was used a positive

    control for Mob phosphorylation.

    E. Knockout of Mst1 and Mst2 in MEF cells does not affect YAP phosphorylation

    induced by cell detachment. Mst1 and Mst2 double knockout MEF cells were

    generated by adenoviral infection of Mst1-/-, Mst2flox/- MEF cells. Ablation of

  •   4  

    Mst1 and Mst2 was confirmed by western blots. Cells were then subjected to

    trypsinization (T), followed by attachment for 2 hours (A), and then re-

    trypsinization (reT). Cell lysates were resolved on Phos-tag-containing SDS-

    PAGE gels and anti-YAP antibody was used for western blot analysis.

    Figure S5. Cell attachment does not regulate interaction of Hippo pathway core

    components.

    A. Cell attachment status does not regulate Mst2-Sav interaction and Lats2-Mob

    interaction. Indicated plasmids were co-transfected into HeLa cells. Cells were

    freshly attached to fibronectin-coated petri dishes for 2 hours or further

    trypsinized. Flag-tagged proteins were immunoprecipitated with anti-Flag

    antibody and co-immunoprecipitation was analyzed by western blots with anti-

    HA antibody.

    B. Cell attachment status does not regulate the formation of the Hippo pathway core

    components complex. Indicated plasmids were co-transfected into HeLa cells.

    Cells were freshly attached to fibronectin-coated petri dishes for 2 hours or further

    trypsinized. Flag-Lats2 was immunoprecipitated with anti-Flag antibody and co-

    immunoprecipitation of other proteins were analyzed by western blots with anti-

    HA antibody.

    Figure S6. Supplemental figure for Fig. 5 and Fig. 6.

  •   5  

    A. YAP induces Erk activation and EMT in detached cells. Cells the same as these in

    Fig. 5C were harvested and lysed for western blot analysis using indicated

    antibodies.

    B. Lats1/2 and YAP/TAZ knockdown efficiency in HMLE, RWPE, and ACHN

    cells. Cells the same as those in Fig. 5D (top panel), Fig. 6A (middle panel), and

    Fig. 6B (bottom panel) were analyzed for knockdown efficiency of indicated

    proteins by western blots.

    C. YAP/TAZ knockdown does not induce anoikis in PC-3 cells. PC-3 cells were

    transfected with control siRNA or siRNAs targeting YAP and TAZ. Cells were

    then cultured on tissue culture plates (Attach) or ultra-low attachment plates in

    suspension. After 72 hours, cells were collected and stained with Annexin V-PE

    and analyzed by FACS.

    D. YAP/TAZ knockdown has only minor effect on inducing anoikis in DU 145 cells.

    Experiments were similar to that in panel C except that DU 145 cells were used.

    E. YAP/TAZ knockdown promotes anoikis in SF268 cells. Experiments were similar

    to that in panel C except that SF268 cells were used.

    F. Histogram showing the expression value of Lats1 and Lats2 in a cohort of

    samples including benign adjacent tissue, localized (PCa) and metastatic (Met)

    prostate tumors. P value measures the statistical difference between metastatic

    prostate cancer when compared to benign and localized prostate cancer.

  • Zhao_FigS1.

    YAP(Phos-tag)

    Attac

    hTry

    p-EDT

    A

    Tryp

    Enzy

    me Fr

    eeA

  • Zhao_FigS2.

    BA

    C

    YAP(Phos-tag)

    AT AAA10 50

    Blebb

    istati

    n (µM

    )

    Cyto

    D (0.

    5 µM)

    YAP(Phos-tag)

    T A AA A AA A APP

    2 5µM

    PF27

    1 1µM

    Lat B

    1µg/m

    l

    Noco

    1µM

    Y276

    32 10

    µM

    Taxo

    l 5µM

    Vinbla

    stin 5

    µM

    YAP(Phos-tag)

    PP2 (µM)

    A T T T T T T T1 10 20 1 5 20

    PF27

    1 (µM

    )

    Blebb

    istati

    n (µM

    )

    Blebb

    istati

    n 20µ

    M

    Y276

    32 10

    µM

    H115

    2 10µ

    M

    -

    D

    YAP(Phos-tag)

    Noco(1μM, 1h)

    Control

    F-actinTubulinE

  • Zhao_FigS3.

    BA

    Tubulin

    Lats1

    Lats2

    Mst1

    Mst2

    Contr

    ol

    Lats1

    +Lats

    2

    Mst1+

    Mst2

    Tubulin

    Lats1

    Lats2

    Mst1

    A TA TA TsiRNA Co

    ntrol

    Lats1

    + Lats

    2

    Mst1+

    Mst2

    Contr

    ol

    Lats1

    + Lats

    2

    Mst1+

    Mst2

    Mst2

    HA

    pLats (T999)

    pLats (S872)

    HA-Lats2+ +

    S872

    AW

    TW

    TW

    T

    Flag-Mst2 - -Lambda PPase - +- -

    C

    siRNA

  • C

    Zhao_FigS4.

    BA

    D

    Mst1

    YAP(phos-tag)

    32P-Mob

    32P-Mst1

    GST-Mob IP

    lysate

    A T A T

    IP C. IgG Mst1

    GST-Mob

    Flag-Mst2 WT KR -A

    WT KR -T

    32P-Mob

    32P-Mst2

    32P-Mob

    (L)

    (S)

    Flag-Mst2

    Flag-Mst2

    pMst2 (T183)TA

    Flag-Mst2 + +

    YAP(Phos-tag)

    T reTA T reTA

    Mst1-/-Mst2cre/-

    Mst1+/+Mst2+/+

    Hsp90

    Mst1

    Mst2

    Mst1-/-Mst2cre/-

    Mst1+/+Mst2+/+

    E

    pMob1 (T35) (S)

    pMob1 (T35) (L)

    Mob1

    H2O2- T reTA

  • Zhao_FigS5.

    BA

    Flag-Lats2 - +

    A T A T A T A T

    -----

    Flag-Mst2HA-Sav

    HA-Mob- -- ---

    -- --

    -- --+

    +++++

    +++++

    IP:Flag

    Lysate

    WB: HA

    WB: Flag

    WB: HA

    WB: Flag

    IP:Flag

    Lysate

    WB: HA

    WB: Flag

    WB: HA

    WB: Flag

    Flag-Lats2 -T A T A

    -

    HA-Mst2HA-Mob

    HA-Sav

    ++++

    ++++++++

    ++

  • Zhao_FigS6.

    CA

    Attach

    Suspension

    Non-targeting siRNA YAP/TAZ siRNA

    6.9% 8.6%

    12.3% 22.5%

    ED

    Attach

    Suspension

    Non-targeting siRNA YAP/TAZ siRNA

    2.5% 1.5%

    3.3% 4.2%

    Attach

    Suspension

    Non-targeting siRNA YAP/TAZ siRNA

    8.9% 5.9%

    14.4% 17.6%

    pERK

    ERK

    E-cad

    N-cad

    Tubulin

    Myc-YAP - WTA S

    5SA - WT 5SA

    F

    -3 -2.5

    -2 -1.5

    -1 -0.5

    0 0.5

    1 1.5

    2 2.5

    1 6 11

    16

    21

    26

    31

    36

    41

    46

    51

    56

    61

    66

    71

    76

    81

    86

    91

    96

    101

    106

    111

    116

    121

    126

    131

    136

    141

    146

    151

    benign PCa Met

    -5

    -4

    -3

    -2

    -1

    0

    1

    2

    1 6 11

    16

    21

    26

    31

    36

    41

    46

    51

    56

    61

    66

    71

    76

    81

    86

    91

    96

    101

    106

    111

    116

    121

    126

    131

    136

    141

    146

    151

    benign PCa Met

    Lats1

    Lats2

    P value

    0.01

    3.28E-06

    B

    P valueLats1+Lats2

    -5

    -4

    -3

    -2

    -1

    0

    1

    2

    3

    4

    1 6 11

    16

    21

    26

    31

    36

    41

    46

    51

    56

    61

    66

    71

    76

    81

    86

    91

    96

    101

    106

    111

    116

    121

    126

    131

    136

    141

    146

    151

    benign PCa Met

    2.30E-08

    Tubulin

    TAZ

    YAP

    Tubulin

    Lats1

    Lats2

    siYAP/TAZ - + - +A S

    siLats1/2 - + - +A S

    Tubulin

    Lats1

    Lats2

    siLats1/2 - + - +A S

    Supplemental Information11-5-11Supplemental figuresFigure S1Figure S2Figure S3Figure S4Figure S5Figure S6